Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.12%) 5 333.50 points
Dow Jones Futures
(0.03%) 40 148 points
Nasdaq Futures
(0.16%) 18 665 points
Oil
(-0.37%) $79.76
Gas
(0.50%) $2.64
Gold
(1.27%) $2 448.20
Silver
(3.11%) $32.23
Platinum
(0.27%) $1 092.90
USD/EUR
(0.05%) $0.920
USD/NOK
(0.00%) $10.68
USD/GBP
(0.03%) $0.787
USD/RUB
(-0.32%) $90.68

Realtime updates for Alliance Pharma PLC [APH.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated20 May 2024 @ 05:19
25% discount on Stockinvest.us - Use code: Podcast

1.84% £ 36.05

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 05:19):

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products...

Stats
Today's Volume 99 393.00
Average Volume 1.55M
Market Cap 194.82M
EPS £0 ( 2024-04-09 )
Last Dividend £1.184 ( 2023-06-22 )
Next Dividend £0 ( N/A )
P/E -36.05
ATR14 £0.272 (0.75%)

Volume Correlation

Long: -0.22 (neutral)
Short: 0.04 (neutral)
Signal:(55.087) Neutral

Alliance Pharma PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alliance Pharma PLC Correlation - Currency/Commodity

The country flag -0.65
( weak negative )
The country flag -0.62
( weak negative )
The country flag -0.75
( moderate negative )
The country flag -0.67
( moderate negative )
The country flag -0.29
( neutral )
The country flag 0.57
( weak )

Alliance Pharma PLC Financials

Annual 2022
Revenue: £167.42M
Gross Profit: £101.68M (60.74 %)
EPS: £0.00170
FY 2022
Revenue: £167.42M
Gross Profit: £101.68M (60.74 %)
EPS: £0.00170
FY 2021
Revenue: £163.21M
Gross Profit: £109.45M (67.06 %)
EPS: £0.0137
FY 2020
Revenue: £129.80M
Gross Profit: £82.82M (63.80 %)
EPS: £0.0154

Financial Reports:

No articles found.

Alliance Pharma PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A) 		£0.592
(N/A) 		£0
(N/A) 		£1.184
(N/A) 		£0
(N/A) 		£0
(N/A) 		£0
(N/A) 		£0
(N/A) 		£0
(N/A) 		£0
(N/A)

Alliance Pharma PLC Dividend Information - Dividend Junior

Dividend Sustainability Score: 6.61 - average (87.25%) | Divividend Growth Potential Score: 1.424 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend £0.0700 2009-12-02
Last Dividend £1.184 2023-06-22
Next Dividend £0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 28 --
Total Paid Out £15.63 --
Avg. Dividend % Per Year 1.27% --
Score 2.99 --
Div. Sustainability Score 6.61
Div.Growth Potential Score 1.424
Div. Directional Score 4.02 --
Next Divdend (Est)
 (2024-10-14)
£1.255 Estimate 3.64 %
Dividend Stability
0.29 Very Poor
Dividend Score
2.99
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2009 £0.0700 2.33%
2010 £0.400 1.48%
2011 £0.650 2.11%
2012 £0.775 2.51%
2013 £0.853 2.67%
2014 £0.938 2.32%
2015 £1.033 2.79%
2016 £1.137 2.65%
2017 £1.250 2.75%
2018 £1.375 2.04%
2019 £1.513 2.30%
2020 £0.536 0.63%
2021 £2.20 2.50%
2022 £1.720 1.57%
2023 £1.184 2.17%
2024 £0 0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SEIT.L Dividend Knight 2023-09-14 Quarterly 6 3.23%
HUR.L Dividend King 2023-06-08 Insufficient data to determine frequency 2 21.63%
BATS.L Dividend Knight 2023-09-28 Quarterly 30 3.98%
YU.L Dividend Junior 2023-06-01 Sporadic 9 0.14%
NCYF.L Dividend King 2023-07-27 Quarterly 20 4.98%
ECEL.L Dividend Knight 2023-09-14 Annually 10 2.87%
SPT.L Dividend Knight 2023-08-10 Semi-Annually 32 1.51%
ITRK.L Dividend Knight 2023-09-14 Semi-Annually 22 1.44%
BRBY.L Dividend Knight 2023-06-29 Annually 22 1.53%
PHP.L Dividend King 2023-07-06 Quarterly 28 2.84%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.04151.500-0.830-1.245[0 - 0.5]
returnOnAssetsTTM-0.01371.200-0.458-0.550[0 - 0.3]
returnOnEquityTTM-0.02501.500-1.389-2.08[0.1 - 1]
payoutRatioTTM-1.315-1.000-10.0010.00[0 - 1]
currentRatioTTM1.9310.8005.354.28[1 - 3]
quickRatioTTM1.3330.8006.865.49[0.8 - 2.5]
cashRatioTTM0.5331.5008.1510.00[0.2 - 2]
debtRatioTTM0.242-1.5005.96-8.94[0 - 0.6]
interestCoverageTTM3.051.0009.989.98[3 - 30]
operatingCashFlowPerShareTTM0.04022.009.9910.00[0 - 30]
freeCashFlowPerShareTTM0.03972.009.9810.00[0 - 20]
debtEquityRatioTTM0.449-1.5008.20-10.00[0 - 2.5]
grossProfitMarginTTM0.5161.0004.744.74[0.2 - 0.8]
operatingProfitMarginTTM0.1441.0009.139.13[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1741.000-0.143-0.143[0.2 - 2]
assetTurnoverTTM0.3310.800-1.127-0.901[0.5 - 2]
Total Score6.61

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-27.081.000-2.840[1 - 100]
returnOnEquityTTM-0.02502.50-0.893-2.08[0.1 - 1.5]
freeCashFlowPerShareTTM0.03972.009.9910.00[0 - 30]
dividendYielPercentageTTM3.341.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.04022.009.9910.00[0 - 30]
payoutRatioTTM-1.3151.500-10.0010.00[0 - 1]
pegRatioTTM-279.511.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1281.0009.310[0.1 - 0.5]
Total Score1.424

Alliance Pharma PLC Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Alliance Pharma PLC

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators